The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted into an Institute on 26th January 2002. Under the World Bank TEQIP programme, the Maharashtra government granted it full autonomy in June 2004. Due to the recommendations of the Government of Maharashtra and the University of Mumbai, the ICT was granted Deemed University Status by the MHRD on 12th September 2008, with all provisions of the UGC for funding and support as the state-owned deemed university.

Applications are invited for the post of Junior Research Fellow.

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme (Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

Lingaya‘s University is guided by the noble patriotic thoughts of the great freedom fighter Late Shri Gadde Lingaya and also by the academic vision of Late Prof GVK Sinha, the founder Chairman of Lingayas Group of Institutions. The motto of the Group is ―Par Excellence with Human Touch. The Lingaya`s Institute of Management & Technology (LIMAT) established in year 1998 was transformed into Lingaya‘s University in the year 2009 as deemed to be University under Section 3 of UGC Act 1956. Lingaya`s Institute of Management & Technology (LIMAT), was approved by All India Council for Technical Education (AICTE) and was affiliated to M.D. University, Rohtak.

Post : Assistant Professors in Pharmaceutical Chemistry & Pharmaceutics

Nehru Yuva Krida & Sanskrutik Mandal, Chikhli. Dist: Buldana (M.S.) was established in the year 1993. The society was established with the aim that it would provide quality education to the students from the remote places, by running different educational institutes in the form of college, school, technical institutes, Niwasi Schools etc.  The management started Gawande College of Pharmacy, from 2015-16 initially for D.Pharm course  (2 years duration) with 60 intake capacity, thereafter from 2017-18 B.Pharm course (4 years duration) is started with intake capacity of 100 students. The College is approved by all apex bodies like AICTE/State Govt/DTE/PCI/MSBTE and Sant Gadge Baba Amravati University.

Post : Assistant Professor (Pharmachemisrty/QA/Pharmacognosy

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

Post : Executive/ Sr. Executive

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.  Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Intas is currently ranked 10th in the Indian Pharma Market with 2.80% market share. (as per IMS Health India, Secondary Stockiest Audit (SSA), Nov 16, 2016 MAT).

Hetero Drugs established in the year 1993, with the motto to be the best in the API manufacturing, Hetero today embodies the vision of a top notch player in developing and commercialising products catering to a variety of therapeutic categories, integrating into a leading finished dosage manufacturer. True to the Statement, "Where the Future Started Yesterday", with a foresight on the current trends in the Pharmaceutical Market, Hetero has grown from strength to strength, combining its Research Strengths, Manufacturing Capabilities ,Human Resources and well established quality management system.

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.  Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Intas is currently ranked 10th in the Indian Pharma Market with 2.80% market share. (as per IMS Health India, Secondary Stockiest Audit (SSA), Nov 16, 2016 MAT).

Johnson & Johnson, through its operating companies, is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices markets. Johnson & Johnson strives to provide scientifically sound, high quality products and services to help heal, cure disease and improve the quality of life. The organization is comprised of more than 250 operating companies with over 127,000 employees located in some 60 countries. With Global sales of USD 71.3 billion in 2013, Johnson & Johnson is recognized as one of the most admired and respected companies in the world. Johnson & Johnson companies are equal opportunity employers.

Post : Senior QMS Lead

The earliest known inhabitants of the region were tribals called Dasas. Later, Aryans came and they assimilated in the tribes. In the later centuries, the hill chieftains accepted suzerainty of the Mauryan empire, the Kaushans, the Guptas and Kanuaj rulers. During the Mughal period, the Rajas of the hill states made some mutually agreed arrangements which governed their relations. In the 19th century, Ranjit Singh annexed/subjugated many of the states. When the British came, they defeated Gorkhas and entered into treaties with some Rajas and annexed the kingdoms of others. The situation more or less remained unchanged till 1947. After Independence, 30 princely states of the area were united and Himachal Pradesh was formed on 15th April, 1948.

REQUISTION TO BE USED FOR APPLICATION FOR EMPLOYMENT EXCHANGES FOR RECRUITMENT OF PHARMACIST (ALLOPATHY) AGAINST VACANCIES PURELY ON BATCH WISE BASIS AND CONTRACT BASIS .

Post : PHARMACIST (ALLOPATHY)

Application are invited for post of Pharmacist (Ayurveda) (Contractual) at Office of Andaman & Nicobar State Ayush Society.

[adsense:336x280:8701650588]

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Tabassum I. Hangad *, Rani S. Potawale
Department of Pharmaceutical Chemistry,
M. C. E. Society's Allana College of Pharmacy, Azam Campus ,Camp, Pune 411001.

ABSTRACT
Ivabradine is a specific heart rate lowering agent, acting by reducing the rate of pacemaker
activity in the sinoatrial node. Ivabradine is a novel heart rate lowering medicine for the symptomatic management of stable angina pectoralis and symptomatic chronic heart failure. In multicenter clinical trials, it has been proved that Ivabradine is superior to beta-blocking agents during complex therapy of chronic heart failure accompanied with its beneficial effects related to cardiac remodeling, improvement of the currency of heart failure and diminution of patients rehospitalisation. It is suggested that Ivabradine as a newer agent is a valuable perspective drug for the treatment of congestive heart failure. This review is useful for the future study for researcher involved in formulation development and quality control of Ivabradine.

This review article represents the various analytical methods which have been reported for estimation of Ivabradine in pharmaceutical dosage form. The spectrophotometric techniques and Q-absorbance ratio method were reported by the various authors. Many researchers also worked in chromatographic areas like Thin layer chromatography, High performance liquid chromatography, and High performance thin layer chromatography. Ivabradine is also studied by various hyphenated techniques .We reviewed and reported almost all analytical methods with more emphasis on chromatographic mrthodsfor Ivabradine. 

[adsense:336x280:8701650588]

The Indian Institute of Technology Gandhinagar strives to offer the best undergraduate and graduate education in India with unmatched innovations in curriculum. The institute promotes critical thinking and an appreciation of the interdisciplinary character of knowledge, with an emphasis on the liberal arts, project oriented learning, compulsory courses in design and the life sciences, diversity and globalization. The five-week immersion Foundation Programme for all new undergraduate students was recognized with the World Education Award 2013 by the World Education Summit for innovations in engineering education. Nearly a quarter of its undergraduate students receive study abroad experience during their academic career.

Applications are invited for the position of “Research Associate” on a research project funded by the Council of Scientific and Industrial Research (CSIR). The project is to be completed at Indian Institute of Technology Gandhinagar.

Post : Research Associate

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits.

Post : Sr. Research Associate/ Research Scientist

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Regional Training Manager

The Central University of Rajasthan has been established by an Act of Parliament (Act No. 25 of 2009, The Gazette of India, No. 27, published on 20th March, 2009 as a new Central University, and is fully funded by the Government of India. The President of India, His Excellency Shri Pranab Mukherjee, is the Visitor of the Central University of Rajasthan.

Applications are invited for the post of Project Assistant on contract basis to work on the DST-sponsored research project entitled “Development of Sustainable Reactions and Methods using Dibenzothiophene 5,5-dioxide: Synthesis of pi-Conjugated Systems”, sanctioned to Dr. M. Bhanuchandra, Assistant Professor at the Central University of Rajasthan (CURAJ).

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities. The state-of-the-art research facilities have been qualified by various pharmaceutical majors & regulatory agencies and has received various certifications including ISO 9001: 2008, ISO 14001:2004, OHSAS 18001:2007, GLP and AAALAC.

Post : Senior Research Associate

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach. We leverage local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.

Post : Clinical Research Associate

THE INSTITUTE SBSPGI came into existence in 1994 and is the flag bearer of education and research in the prime areas of biomedical sciences and technology. This institute was the vision of late Sardar Gurcharan Singh Ji, who foresaw the necessity of providing professional education in the era of late eighties-early nineties, when this was mainly confined to the southern state. He undertook the herculean task of establishing a premier Institute SBSPGI, a sacred abode of learning in the foothills of the Shivaliks. Today, his dreams have been realized in the shape of SBSPGI, which constitutes of School of Pharmaceutical Sciences and Applied Chemistry, School of Life sciences and School of Allied Health Sciences, imparting finest education in their respective fields.